Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

PUBLIC HEALTH

The benefits and risks of mass antibiotic use for reducing child mortality

Nature Medicine volume 25, pages 1332–1334 (2019)Cite this article

Subjects

Mass administration of azithromycin to young children at risk of dying could reduce harmful intestinal pathogenic bacteria and impact survival, but also increase antibiotic resistance.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Fig. 1

References

  1. Doan. T. et al. Nat. Med. https://doi.org/10.1038/s41591-019-0533-0 (2019).

  2. Porco, T. C. et al. J. Am. Med. Assoc. 302, 962–968 (2009).

    Article  CAS  Google Scholar 

  3. Keenan, J. D. et al. N. Engl. J. Med. 378, 1583–1592 (2018).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Oldenburg, C. E. et al. Am. J. Trop. Med. Hyg. 100, 691–695 (2019).

    Article  PubMed  PubMed Central  Google Scholar 

  5. Arzika, A. M. et al. PLoS Med. 16, e1002835 (2019).

    Article  PubMed  PubMed Central  Google Scholar 

  6. Chandramohan, D. et al. N. Engl. J. Med. 380, 2197–2206 (2019).

    Article  PubMed  Google Scholar 

  7. Doan, T. et al. Open Forum Infect. Dis. 5, ofy182, https://doi.org/10.1093/ofid/ofy182 (2018).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Liu, J. et al. Lancet 388, 1291–1301 (2016).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Rogawski, E.T. et al. Lancet Glob. Health 6, e1319–e1328.

  10. Whitty, C. J., Glasgow, K. W., Sadiq, S. T., Mabey, D. C. & Bailey, R. Pediatr. Infect. Dis. J. 18, 955–958 (1999).

    Article  CAS  PubMed  Google Scholar 

  11. Keenan, J. D. et al. PLoS Negl. Trop. Dis. 13, e0007442 (2019).

    Article  PubMed  PubMed Central  Google Scholar 

  12. Doan, T. et al. N. Engl. J. Med. 380, 2271–2273 (2019).

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Robert Harding Chair in Global Child Health & Policy, Centre for Global Child Health, The Hospital for Sick Children, Toronto, Ontario, Canada

    Zulfiqar A. Bhutta

  2. Founding Director, Center of Excellence in Women and Child Health, The Aga Khan University, Karachi, Pakistan

    Zulfiqar A. Bhutta

Authors
  1. Zulfiqar A. Bhutta
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Zulfiqar A. Bhutta.

Ethics declarations

Competing interests

The author declares no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bhutta, Z.A. The benefits and risks of mass antibiotic use for reducing child mortality. Nat Med 25, 1332–1334 (2019). https://doi.org/10.1038/s41591-019-0576-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41591-019-0576-2

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing